Found: 17
Select item for more details and to access through your institution.
Targeting Mitochondria for Treatment of Chemoresistant Ovarian Cancer.
- Published in:
- International Journal of Molecular Sciences, 2019, v. 20, n. 1, p. 229, doi. 10.3390/ijms20010229
- By:
- Publication type:
- Article
Emerging Therapeutics to Overcome Chemoresistance in Epithelial Ovarian Cancer: A Mini-Review.
- Published in:
- International Journal of Molecular Sciences, 2017, v. 18, n. 10, p. 2171, doi. 10.3390/ijms18102171
- By:
- Publication type:
- Article
The Importance of the PI3K/AKT/MTOR Pathway in the Progression of Ovarian Cancer.
- Published in:
- International Journal of Molecular Sciences, 2013, v. 14, n. 4, p. 8213, doi. 10.3390/ijms14048213
- By:
- Publication type:
- Article
Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma.
- Published in:
- Nature Medicine, 2006, v. 12, n. 8, p. 939, doi. 10.1038/nm1447
- By:
- Publication type:
- Article
Effect of Interleukin-8 Gene Silencing With Liposome-Encapsulated Small Interfering RNA on Ovarian Cancer Cell Growth.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2008, v. 100, n. 5, p. 359, doi. 10.1093/jnci/djn024
- By:
- Publication type:
- Article
Efficacy and Antivascular Effects of EphA2 Reduction With an Agonistic Antibody in Ovarian Cancer.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2006, v. 98, n. 21, p. 1558, doi. 10.1093/jnci/djj414
- By:
- Publication type:
- Article
Credentialing and Pharmacologically Targeting PTP4A3 Phosphatase as a Molecular Target for Ovarian Cancer.
- Published in:
- Biomolecules (2218-273X), 2021, v. 11, n. 7, p. 969, doi. 10.3390/biom11070969
- By:
- Publication type:
- Article
CX-5461 Treatment Leads to Cytosolic DNA-Mediated STING Activation in Ovarian Cancer.
- Published in:
- Cancers, 2021, v. 13, n. 20, p. 5056, doi. 10.3390/cancers13205056
- By:
- Publication type:
- Article
EphA2 overexpression is associated with angiogenesis in ovarian cancerPresented at the 97th Annual Meeting of the American Association for Cancer Research, Washington D.C., April 1‐5, 2006.
- Published in:
- Cancer (0008543X), 2007, v. 109, n. 2, p. 332, doi. 10.1002/cncr.22415
- By:
- Publication type:
- Article
EDD enhances cell survival and cisplatin resistance and is a therapeutic target for epithelial ovarian cancer.
- Published in:
- Carcinogenesis, 2014, v. 35, n. 5, p. 1100, doi. 10.1093/carcin/bgt489
- By:
- Publication type:
- Article
A Novel Monoclonal Antibody Targeting Cancer-Specific Plectin Has Potent Antitumor Activity in Ovarian Cancer.
- Published in:
- Cells (2073-4409), 2021, v. 10, n. 9, p. 2218, doi. 10.3390/cells10092218
- By:
- Publication type:
- Article
Arsenic trioxide and tetraarsenic oxide induce cytotoxicity and have a synergistic effect with cisplatin in paclitaxel-resistant ovarian cancer cells.
- Published in:
- Acta Oncologica, 2019, v. 58, n. 11, p. 1594, doi. 10.1080/0284186X.2019.1630750
- By:
- Publication type:
- Article
Platinum Chemotherapy Induces Lymphangiogenesis in Cancerous and Healthy Tissues That Can be Prevented With Adjuvant Anti-VEGFR3 Therapy.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.801764
- By:
- Publication type:
- Article
Enhancement of Cisplatin-Mediated Apoptosis in Ovarian Cancer Cells through Potentiating G2/M Arrest and p21 Upregulation by Combinatorial Epigallocatechin Gallate and Sulforaphane.
- Published in:
- Journal of Oncology, 2013, p. 1, doi. 10.1155/2013/872957
- By:
- Publication type:
- Article
Silencing of p130Cas in Ovarian Carcinoma: A Novel Mechanism for Tumor Cell Death.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2011, v. 103, n. 21, p. 1596, doi. 10.1093/jnci/djr372
- By:
- Publication type:
- Article
EphA2 Immunoconjugate as Molecularly Targeted Chemotherapy for Ovarian Carcinoma.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2009, v. 101, n. 17, p. 1193, doi. 10.1093/jnci/djp231
- By:
- Publication type:
- Article
ST6Gal-I sialyltransferase confers cisplatin resistance in ovarian tumor cells.
- Published in:
- Journal of Ovarian Research, 2013, v. 6, n. 1, p. 1, doi. 10.1186/1757-2215-6-25
- By:
- Publication type:
- Article